ESF Stock Overview
Provides various analytical testing and laboratory services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Eurofins Scientific SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €47.11 |
| 52 Week High | €61.22 |
| 52 Week Low | €44.67 |
| Beta | 0.74 |
| 11 Month Change | 0.66% |
| 3 Month Change | -10.68% |
| 1 Year Change | -11.85% |
| 33 Year Change | -58.68% |
| 5 Year Change | n/a |
| Change since IPO | -29.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| ESF | AT Life Sciences | AT Market | |
|---|---|---|---|
| 7D | 3.5% | 2.2% | -0.6% |
| 1Y | -11.8% | 3.6% | 2.5% |
Return vs Industry: ESF underperformed the Austrian Life Sciences industry which returned 3.6% over the past year.
Return vs Market: ESF underperformed the Austrian Market which returned 2.5% over the past year.
Price Volatility
| ESF volatility | |
|---|---|
| ESF Average Weekly Movement | 4.8% |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in AT Market | 6.6% |
| 10% least volatile stocks in AT Market | 1.8% |
Stable Share Price: ESF's share price has been volatile over the past 3 months compared to the Austrian market.
Volatility Over Time: ESF's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 61,798 | Gilles Martin | www.eurofins.com |
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics.
Eurofins Scientific SE Fundamentals Summary
| ESF fundamental statistics | |
|---|---|
| Market cap | €8.89b |
| Earnings (TTM) | €325.90m |
| Revenue (TTM) | €6.72b |
27.3x
P/E Ratio1.3x
P/S RatioIs ESF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ESF income statement (TTM) | |
|---|---|
| Revenue | €6.72b |
| Cost of Revenue | €5.23b |
| Gross Profit | €1.49b |
| Other Expenses | €1.17b |
| Earnings | €325.90m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 26, 2025
| Earnings per share (EPS) | 1.72 |
| Gross Margin | 22.19% |
| Net Profit Margin | 4.85% |
| Debt/Equity Ratio | 55.3% |
How did ESF perform over the long term?
See historical performance and comparison